Pembrolizumab for the treatment of Hodgkin Lymphoma

.

Source: Expert Opinion on Biological Therapy - October 16, 2020 Category: Drugs & Pharmacology Authors: Samer A. Al Hadidi Hun Ju Lee Source Type: research